サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1266328

補助人工心臓市場：製品別、用途別、設計別、年齢別：世界の機会分析と産業予測、2021-2031年

Ventricular Assist Devices Market By Product, By Application, By Design, By Age : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日: | 発行: Allied Market Research | ページ情報: 英文 316 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
補助人工心臓市場：製品別、用途別、設計別、年齢別：世界の機会分析と産業予測、2021-2031年
出版日: 2023年02月01日
発行: Allied Market Research
ページ情報: 英文 316 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

補助人工心臓市場は、2021年に13億3,853万米ドルと評価され、2022年から2031年にかけて7.9%のCAGRを示し、2031年には28億8,066万米ドルに達すると予測されています。

補助人工心臓（VAD）は、機械的循環支援（MCS）装置としても知られ、心臓のポンプ機能をサポートします。患者の体内を流れる血液の量を増やすために使用されます。これにより、進行した心不全の患者さんは、再び生活の質を向上させることができます。補助人工心臓は、右心室と左心室のいずれかをサポートするものですが、多くは左心室に留置されます。左心室に留置される場合は、左心室補助循環装置（LVAD）と呼ばれます。

補助人工心臓は、心不全の治療でよく使われます。VAD移植は、移植される機能によって一時的なものと永続的なものがあります。患者さんが心臓移植を待っているか、心臓が自力で血液を送り出せるほど健康になるまで回復を助ける治療を受けているときに、一時的に移植されます。

一方、心室機能に異常がある患者さんには、心臓を通る血流を適切に確保するために永久的に植え付けられます。このような心不全治療への応用により、補助人工心臓はヘルスケア分野での需要が高まり、市場の成長を後押ししています。また、補助人工心臓に関する患者やヘルスケア関係者の意識の高まりが、市場の成長を後押ししています。

さらに、政府やその他の団体が、心血管疾患やその高度な治療法に関する人々の意識を高めるために行っている取り組みがあります。例えば、イングランドの国民保健サービス（NHS）長期計画では、プライマリケアネットワーク（PCN）を通じた地域での心不全の早期発見の促進、集学的チーム（MDT）主導のケアの強化、病院での専門治療への迅速なアクセスに焦点を当て、2019年の優先事項として心不全を指定しています。また、様々な団体による啓発活動により、補助人工心臓をはじめとする心不全の先進的な治療法に関する一般の人々の認識が高まっています。これが、補助人工心臓市場の拡大にさらにつながっています。

様々な要因が市場の成長を後押ししていますが、補助人工心臓に関連する高額な費用や、手術に伴う重大なリスクなどが、市場の成長を妨げています。これらの高価格は、主に発展途上国や低開発国において、補助人工心臓へのアクセスに制限を与えています。さらに、低開発国の人々の心不全の高度な治療方法に関する認識不足も、市場の成長抑制要因となっています。さらに、補助人工心臓の植え込みは、手術による血栓や出血で感染症や装置の誤作動を引き起こす可能性があり、これが市場の抑制要因となっています。

一方、主要な市場関係者は、補助人工心臓に関連する研究開発活動のために大規模な投資を行っています。企業は、既存の補助人工心臓の欠点を克服することができる高度な補助人工心臓を開発するための技術革新に注力しています。さらに、補助人工心臓の効率性を証明し、その承認を得るために、数多くの臨床試験や開発研究が行われています。このことは、予測期間中の市場拡大を促進すると予想されます。

例えば、2022年10月、アビオメッドは、Impella RP Flex with SmartAssistが、最大14日間の急性右心不全の治療に安全かつ有効であるとして、米国食品医薬品局（FDA）の市販前承認（PMA）を取得したと発表しました。このような製品の承認や発売は、市場の成長に寄与しています。さらに、世界の心不全の急増、補助人工心臓の新技術の進歩、心臓のモニタリングに関する患者の意識、心臓ドナーの不足などが、市場の成長を後押ししています。

補助人工心臓市場は、製品、アプリケーション、デザイン、年齢、地域によって区分されます。製品別では、左心室補助装置（LVAD）、右心室補助装置（RVAD）、両心室補助装置（BIVAD）に分類されます。用途別では、移植への橋渡し（BTT）、目的地治療、回復への橋渡し（BTR）、候補地治療への橋渡しに細分化されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な影響要因
    • 主な投資ポケット
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 代替品の脅威
    • 新規参入業者の脅威
    • 競争の激しさ
  • 市場力学
    • 促進要因
      • 心不全の発生率の増加
      • 技術の進歩
      • 心不全治療の選択肢に関する患者の意識の高まり
      • 心臓ドナーの不足
    • 抑制要因
      • 装置と手順の高コスト
      • 手順に伴う重大なリスク
    • 機会
      • 新興市場における有利な機会
  • 市場におけるCOVID-19影響分析

第4章 補助人工心臓市場：製品別

  • 概要
    • 市場規模と予測
  • 左心室補助装置（LVAD）
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • 右心室補助装置（RVAD）
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • 両室補助装置（BIVAD）
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別

第5章 補助人工心臓市場：用途別

  • 概要
    • 市場規模と予測
  • ブリッジツートランスプラント（BTT）
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • デスティネーション・セラピー
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • Bridge-to-Recovery（BTR）
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • 立候補療法への架け橋
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別

第6章 補助人工心臓市場：設計別

  • 概要
    • 市場規模と予測
  • 経皮的補助人工心臓
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • 植込み型補助人工心臓
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別

第7章 補助人工心臓市場：年齢別

  • 概要
    • 市場規模と予測
  • 大人
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • 小児科
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別

第8章 補助人工心臓市場：地域別

  • 概要
    • 市場規模と予測：地域別
  • 北米
    • 主な動向と機会
    • 市場規模と予測：製品別
    • 市場規模と予測：用途別
    • 市場規模と予測：設計別
    • 市場規模と予測：年代別
    • 市場規模と予測：国別
      • 米国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：設計別
      • 市場規模と予測：年代別
      • カナダ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：設計別
      • 市場規模と予測：年代別
      • メキシコ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：設計別
      • 市場規模と予測：年代別
  • 欧州
    • 主な動向と機会
    • 市場規模と予測：製品別
    • 市場規模と予測：用途別
    • 市場規模と予測：設計別
    • 市場規模と予測：年代別
    • 市場規模と予測：国別
      • ドイツ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：設計別
      • 市場規模と予測：年代別
      • フランス
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：設計別
      • 市場規模と予測：年代別
      • 英国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：設計別
      • 市場規模と予測：年代別
      • イタリア
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：設計別
      • 市場規模と予測：年代別
      • スペイン
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：設計別
      • 市場規模と予測：年代別
      • その他欧州
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：設計別
      • 市場規模と予測：年代別
  • アジア太平洋
    • 主な動向と機会
    • 市場規模と予測：製品別
    • 市場規模と予測：用途別
    • 市場規模と予測：設計別
    • 市場規模と予測：年代別
    • 市場規模と予測：国別
      • 日本
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：設計別
      • 市場規模と予測：年代別
      • 中国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：設計別
      • 市場規模と予測：年代別
      • オーストラリア
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：設計別
      • 市場規模と予測：年代別
      • インド
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：設計別
      • 市場規模と予測：年代別
      • 韓国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：設計別
      • 市場規模と予測：年代別
      • その他アジア太平洋地域
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：設計別
      • 市場規模と予測：年代別
  • ラテンアメリカ・中東・アフリカ
    • 主な動向と機会
    • 市場規模と予測：製品別
    • 市場規模と予測：用途別
    • 市場規模と予測：設計別
    • 市場規模と予測：年代別
    • 市場規模と予測：国別
      • ブラジル
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：設計別
      • 市場規模と予測：年代別
      • サウジアラビア
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：設計別
      • 市場規模と予測：年代別
      • 南アフリカ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：設計別
      • 市場規模と予測：年代別
      • ラテンアメリカ・中東・アフリカの残り
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：設計別
      • 市場規模と予測：年代別

第9章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • トップ企業のポジショニング、2021年

第10章 企業プロファイル

  • Evaheart, Inc.
  • Calon Cardio-Technology Ltd
  • Carmat SA
  • Fineheart
  • AdjuCor GmbH
  • Corewave SA
  • Bivacor Inc.
  • Windmill Cardiovascular Systems
  • NuPulseCV, Inc.
  • Abiomed, Inc.
  • LivaNova PLC
  • Berlin Heart GmbH
  • Jarvik Heart, Inc.
  • Abbott Laboratories
  • SynCardia Systems, LLC
  • CH Biomedical, Inc.
図表

LIST OF TABLES

  • TABLE 01. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 02. VENTRICULAR ASSIST DEVICES MARKET FOR LEFT VENTRICULAR ASSIST DEVICES (LVADS), BY REGION, 2021-2031 ($MILLION)
  • TABLE 03. VENTRICULAR ASSIST DEVICES MARKET FOR RIGHT VENTRICULAR ASSIST DEVICES (RVADS), BY REGION, 2021-2031 ($MILLION)
  • TABLE 04. VENTRICULAR ASSIST DEVICES MARKET FOR BIVENTRICULAR ASSIST DEVICES (BIVADS), BY REGION, 2021-2031 ($MILLION)
  • TABLE 05. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 06. VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE-TO-TRANSPLANT (BTT), BY REGION, 2021-2031 ($MILLION)
  • TABLE 07. VENTRICULAR ASSIST DEVICES MARKET FOR DESTINATION THERAPY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 08. VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE-TO-RECOVERY (BTR), BY REGION, 2021-2031 ($MILLION)
  • TABLE 09. VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE TO CANDIDACY THERAPY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 11. VENTRICULAR ASSIST DEVICES MARKET FOR TRANSCUTANEOUS VENTRICULAR ASSIST DEVICES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. VENTRICULAR ASSIST DEVICES MARKET FOR IMPLANTABLE VENTRICULAR ASSIST DEVICES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 13. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 14. VENTRICULAR ASSIST DEVICES MARKET FOR ADULTS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 15. VENTRICULAR ASSIST DEVICES MARKET FOR PEDIATRICS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. VENTRICULAR ASSIST DEVICES MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 17. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 18. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 19. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 20. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 21. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 22. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 23. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 24. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 25. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 26. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 27. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 28. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 29. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 30. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 31. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 32. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 33. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 34. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 35. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 36. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 37. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 38. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 39. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 40. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 41. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 42. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 43. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 44. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 45. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 46. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 47. UK VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 48. UK VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 49. UK VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 50. UK VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 51. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 52. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 53. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 54. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 55. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 56. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 57. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 58. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 59. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 60. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 61. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 62. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 63. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 64. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 65. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 66. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 67. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 68. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 69. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 70. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 71. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 72. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 73. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 74. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 75. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 76. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 77. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 78. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 79. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 80. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 81. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 82. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 83. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 84. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 85. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 86. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 87. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 88. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 89. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 90. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 91. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 92. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 93. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 94. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 95. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 96. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 97. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 98. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 99. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 100. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 101. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 102. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 103. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 104. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 105. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 106. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 107. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 108. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 109. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 110. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 111. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
  • TABLE 112. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
  • TABLE 113. EVAHEART, INC.: KEY EXECUTIVES
  • TABLE 114. EVAHEART, INC.: COMPANY SNAPSHOT
  • TABLE 115. EVAHEART, INC.: PRODUCT SEGMENTS
  • TABLE 116. EVAHEART, INC.: PRODUCT PORTFOLIO
  • TABLE 117. EVAHEART, INC.: KEY STRATERGIES
  • TABLE 118. CALON CARDIO-TECHNOLOGY LTD: KEY EXECUTIVES
  • TABLE 119. CALON CARDIO-TECHNOLOGY LTD: COMPANY SNAPSHOT
  • TABLE 120. CALON CARDIO-TECHNOLOGY LTD: PRODUCT SEGMENTS
  • TABLE 121. CALON CARDIO-TECHNOLOGY LTD: PRODUCT PORTFOLIO
  • TABLE 122. CARMAT SA: KEY EXECUTIVES
  • TABLE 123. CARMAT SA: COMPANY SNAPSHOT
  • TABLE 124. CARMAT SA: PRODUCT SEGMENTS
  • TABLE 125. CARMAT SA: PRODUCT PORTFOLIO
  • TABLE 126. CARMAT SA: KEY STRATERGIES
  • TABLE 127. FINEHEART: KEY EXECUTIVES
  • TABLE 128. FINEHEART: COMPANY SNAPSHOT
  • TABLE 129. FINEHEART: PRODUCT SEGMENTS
  • TABLE 130. FINEHEART: PRODUCT PORTFOLIO
  • TABLE 131. FINEHEART: KEY STRATERGIES
  • TABLE 132. ADJUCOR GMBH: KEY EXECUTIVES
  • TABLE 133. ADJUCOR GMBH: COMPANY SNAPSHOT
  • TABLE 134. ADJUCOR GMBH: PRODUCT SEGMENTS
  • TABLE 135. ADJUCOR GMBH: PRODUCT PORTFOLIO
  • TABLE 136. COREWAVE SA: KEY EXECUTIVES
  • TABLE 137. COREWAVE SA: COMPANY SNAPSHOT
  • TABLE 138. COREWAVE SA: PRODUCT SEGMENTS
  • TABLE 139. COREWAVE SA: PRODUCT PORTFOLIO
  • TABLE 140. COREWAVE SA: KEY STRATERGIES
  • TABLE 141. BIVACOR INC.: KEY EXECUTIVES
  • TABLE 142. BIVACOR INC.: COMPANY SNAPSHOT
  • TABLE 143. BIVACOR INC.: PRODUCT SEGMENTS
  • TABLE 144. BIVACOR INC.: PRODUCT PORTFOLIO
  • TABLE 145. BIVACOR INC.: KEY STRATERGIES
  • TABLE 146. WINDMILL CARDIOVASCULAR SYSTEMS: KEY EXECUTIVES
  • TABLE 147. WINDMILL CARDIOVASCULAR SYSTEMS: COMPANY SNAPSHOT
  • TABLE 148. WINDMILL CARDIOVASCULAR SYSTEMS: PRODUCT SEGMENTS
  • TABLE 149. WINDMILL CARDIOVASCULAR SYSTEMS: PRODUCT PORTFOLIO
  • TABLE 150. NUPULSECV, INC.: KEY EXECUTIVES
  • TABLE 151. NUPULSECV, INC.: COMPANY SNAPSHOT
  • TABLE 152. NUPULSECV, INC.: PRODUCT SEGMENTS
  • TABLE 153. NUPULSECV, INC.: PRODUCT PORTFOLIO
  • TABLE 154. ABIOMED, INC.: KEY EXECUTIVES
  • TABLE 155. ABIOMED, INC.: COMPANY SNAPSHOT
  • TABLE 156. ABIOMED, INC.: PRODUCT SEGMENTS
  • TABLE 157. ABIOMED, INC.: PRODUCT PORTFOLIO
  • TABLE 158. ABIOMED, INC.: KEY STRATERGIES
  • TABLE 159. LIVANOVA PLC: KEY EXECUTIVES
  • TABLE 160. LIVANOVA PLC: COMPANY SNAPSHOT
  • TABLE 161. LIVANOVA PLC: PRODUCT SEGMENTS
  • TABLE 162. LIVANOVA PLC: PRODUCT PORTFOLIO
  • TABLE 163. LIVANOVA PLC: KEY STRATERGIES
  • TABLE 164. BERLIN HEART GMBH: KEY EXECUTIVES
  • TABLE 165. BERLIN HEART GMBH: COMPANY SNAPSHOT
  • TABLE 166. BERLIN HEART GMBH: PRODUCT SEGMENTS
  • TABLE 167. BERLIN HEART GMBH: PRODUCT PORTFOLIO
  • TABLE 168. BERLIN HEART GMBH: KEY STRATERGIES
  • TABLE 169. JARVIK HEART, INC.: KEY EXECUTIVES
  • TABLE 170. JARVIK HEART, INC.: COMPANY SNAPSHOT
  • TABLE 171. JARVIK HEART, INC.: PRODUCT SEGMENTS
  • TABLE 172. JARVIK HEART, INC.: PRODUCT PORTFOLIO
  • TABLE 173. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 174. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 175. ABBOTT LABORATORIES: PRODUCT SEGMENTS
  • TABLE 176. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 177. ABBOTT LABORATORIES: KEY STRATERGIES
  • TABLE 178. SYNCARDIA SYSTEMS, LLC: KEY EXECUTIVES
  • TABLE 179. SYNCARDIA SYSTEMS, LLC: COMPANY SNAPSHOT
  • TABLE 180. SYNCARDIA SYSTEMS, LLC: PRODUCT SEGMENTS
  • TABLE 181. SYNCARDIA SYSTEMS, LLC: PRODUCT PORTFOLIO
  • TABLE 182. SYNCARDIA SYSTEMS, LLC: KEY STRATERGIES
  • TABLE 183. CH BIOMEDICAL, INC.: KEY EXECUTIVES
  • TABLE 184. CH BIOMEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 185. CH BIOMEDICAL, INC.: PRODUCT SEGMENTS
  • TABLE 186. CH BIOMEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 187. CH BIOMEDICAL, INC.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. VENTRICULAR ASSIST DEVICES MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF VENTRICULAR ASSIST DEVICES MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN VENTRICULAR ASSIST DEVICES MARKET (2022-2031)
  • FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. LOW BARGAINING POWER OF BUYERS
  • FIGURE 06. LOW THREAT OF SUBSTITUTES
  • FIGURE 07. LOW THREAT OF NEW ENTRANTS
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALVENTRICULAR ASSIST DEVICES MARKET
  • FIGURE 10. VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR LEFT VENTRICULAR ASSIST DEVICES (LVADS), BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR RIGHT VENTRICULAR ASSIST DEVICES (RVADS), BY COUNTRY 2021-2031(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR BIVENTRICULAR ASSIST DEVICES (BIVADS), BY COUNTRY 2021-2031(%)
  • FIGURE 14. VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE-TO-TRANSPLANT (BTT), BY COUNTRY 2021-2031(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR DESTINATION THERAPY, BY COUNTRY 2021-2031(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE-TO-RECOVERY (BTR), BY COUNTRY 2021-2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE TO CANDIDACY THERAPY, BY COUNTRY 2021-2031(%)
  • FIGURE 19. VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR TRANSCUTANEOUS VENTRICULAR ASSIST DEVICES, BY COUNTRY 2021-2031(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR IMPLANTABLE VENTRICULAR ASSIST DEVICES, BY COUNTRY 2021-2031(%)
  • FIGURE 22. VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR ADULTS, BY COUNTRY 2021-2031(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR PEDIATRICS, BY COUNTRY 2021-2031(%)
  • FIGURE 25. VENTRICULAR ASSIST DEVICES MARKET BY REGION, 2021
  • FIGURE 26. U.S. VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. CANADA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. MEXICO VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. GERMANY VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. FRANCE VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. UK VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. ITALY VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. SPAIN VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. JAPAN VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. CHINA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. INDIA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 42. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 43. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 44. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
  • FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 48. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 49. COMPETITIVE DASHBOARD
  • FIGURE 50. COMPETITIVE HEATMAP: VENTRICULAR ASSIST DEVICES MARKET
  • FIGURE 51. TOP PLAYER POSITIONING, 2021
  • FIGURE 52. ABIOMED, INC.: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 53. ABIOMED, INC.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 54. LIVANOVA PLC: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 55. LIVANOVA PLC: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 56. LIVANOVA PLC: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 57. ABBOTT LABORATORIES: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 58. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 59. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2021 (%)
目次
Product Code: A01694

The ventricular assist devices market valued for $1,338.53 million in 2021 and is estimated to reach $2,880.66 million by 2031, exhibiting a CAGR of 7.9% from 2022 to 2031.  

Ventricular assist device (VAD), also known as mechanical circulatory support (MCS) device, supports the pumping function of the heart. It is used to increase the amount of blood that flows through the patient's body. It enables a patient with advanced heart failure to lead an improved quality of life once again. A ventricular assist device (VAD) helps in supporting either of the right or the left ventricle, however, is mostly implanted in the left ventricle. When placed in the left ventricle, it is called a left ventricular assist device (LVAD).  

Ventricular assist devices are commonly used in treatment of heart failure. The VAD transplant can be temporary or permanent depending on the function for which it is implanted. They are implanted temporarily when the patient is either waiting for a heart transplant or is receiving treatment to help the heart recover until it is healthy enough to pump blood on its own.  

On the other hand, it is implanted permanently to ensure proper blood flow through the heart in the patient with abnormal ventricle function. Such applications of ventricular assist devices in treatment of heart failure increases its demand in the healthcare sector and thus boost the growth of the market. In addition, rise in awareness among the patients and healthcare practitioners about ventricular assist devices fosters the market growth.  

Moreover, there are initiatives taken up by the governments and other organizations in creating awareness among the people regarding cardiovascular diseases and its advanced treatment options. For instance, the National Health Service (NHS) Long Term Plan for England designated heart failure as a priority in 2019, with a focus on promoting earlier detection of heart failure in the community through primary care networks (PCNs), a stronger emphasis on multidisciplinary teams (MDT)-led care, and quicker access to specialized care in hospitals. Such awareness programs initiated by various organizations increase the public awareness about advanced treatment options in heart failure including the ventricular assist devices. This further leads to the expansion of the ventricular assist devices market. 

Although, various key factors are driving the growth of the market, there are few factors such as high cost associated with the device & implantation and serious risks involved in the procedure are hampering the growth of the market. These high prices create limitations in accessing ventricular assist devices majorly in developing and underdeveloped countries. Moreover, lack of awareness about advanced treatment procedures for heart failure among the people in underdeveloped countries also acts as a restraint to the growth of the market. In addition, implanting a VAD may result in blood clots and bleeding from the surgery that may cause infection and device malfunction, which act as a restraint to the market. 

On the other hand, the key market players are investing on a large scale for the R&D activities related to ventricular assist devices. Companies are focusing on innovation to develop advanced ventricular assist devices that can overcome the drawbacks of the existing VADs. Moreover, large number of clinical and developmental studies are carried out to prove the efficiency of the devices, and to get the approval for the same. This is anticipated to drive the market expansion during the forecast period.  

For instance, in October 2022, Abiomed announced that Impella RP Flex with SmartAssist received U.S. Food and Drug Administration (FDA) pre-market approval (PMA), as safe and effective to treat acute right heart failure for up to 14 days. Thus, more such product approvals and launches contribute to the growth of the market. Moreover, surge in incidences of heart failure across the globe, new technological advancements in ventricular assist devices, awareness among patients about monitoring of the heart, and shortage of heart donors drive the market growth.  

The ventricular assist devices market is segmented on the basis of product, application, design, age, and region. By product, the market is categorized into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BIVADs). On the basis of application, the market is fragmented into bridge-to-transplant (BTT), destination therapy, bridge-to-recovery (BTR), and bridge to candidacy therapy.  

On the basis of design, the market is bifurcated into transcutaneous ventricular assist devices and implantable ventricular assist devices. By age, the market is divided into adults and pediatrics. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Major Key players that operate in the global ventricular assist devices market are: Abbott Laboratories, Abiomed, Inc., AdjuCor GmbH, Berlin Heart GmbH, Bivacor Inc., Calon Cardio-Technology Ltd, Carmat SA, CH Biomedical, Inc., Corewave SA, Evaheart, Inc., Fineheart, Jarvik Heart, Inc., LivaNova PLC, NuPulseCV, Inc., SynCardia Systems, LLC, and Windmill Cardiovascular Systems.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ventricular assist devices market analysis from 2021 to 2031 to identify the prevailing ventricular assist devices market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the ventricular assist devices market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global ventricular assist devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Left Ventricular Assist Devices (LVADs)
  • Right Ventricular Assist Devices (RVADs)
  • Biventricular Assist Devices (BIVADs)

By Application

  • Bridge-To-Transplant (BTT)
  • Destination Therapy
  • Bridge-To-Recovery (BTR)
  • Bridge To Candidacy Therapy

By Design

  • Transcutaneous Ventricular Assist Devices
  • Implantable Ventricular Assist Devices

By Age

  • Adults
  • Pediatrics

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • Evaheart, Inc.
  • Abiomed, Inc.
  • Abbott Laboratories
  • CH Biomedical, Inc.
  • Carmat SA
  • Calon Cardio-Technology Ltd
  • Bivacor Inc.
  • LivaNova PLC
  • Berlin Heart GmbH
  • Fineheart
  • AdjuCor GmbH
  • NuPulseCV, Inc.
  • Jarvik Heart, Inc.
  • SynCardia Systems, LLC
  • Corewave SA
  • Windmill Cardiovascular Systems

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Bargaining power of suppliers
    • 3.3.2. Bargaining power of buyers
    • 3.3.3. Threat of substitutes
    • 3.3.4. Threat of new entrants
    • 3.3.5. Intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in incidence of heart failures
      • 3.4.1.2. Technological advancements
      • 3.4.1.3. Rise in patient awareness about heart failure treatment options
      • 3.4.1.4. Dearth of heart donors
    • 3.4.2. Restraints
      • 3.4.2.1. High cost of devices and procedures
      • 3.4.2.2. Serious risks involved in the procedure
    • 3.4.3. Opportunities
      • 3.4.3.1. Lucrative opportunities in the emerging markets
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Left Ventricular Assist Devices (LVADs)
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Right Ventricular Assist Devices (RVADs)
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Biventricular Assist Devices (BIVADs)
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Bridge-To-Transplant (BTT)
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Destination Therapy
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Bridge-To-Recovery (BTR)
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Bridge To Candidacy Therapy
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Transcutaneous Ventricular Assist Devices
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Implantable Ventricular Assist Devices
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

CHAPTER 7: VENTRICULAR ASSIST DEVICES MARKET, BY AGE

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Adults
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Pediatrics
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country

CHAPTER 8: VENTRICULAR ASSIST DEVICES MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key trends and opportunities
    • 8.2.2. Market size and forecast, by Product
    • 8.2.3. Market size and forecast, by Application
    • 8.2.4. Market size and forecast, by Design
    • 8.2.5. Market size and forecast, by Age
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Key market trends, growth factors and opportunities
      • 8.2.6.1.2. Market size and forecast, by Product
      • 8.2.6.1.3. Market size and forecast, by Application
      • 8.2.6.1.4. Market size and forecast, by Design
      • 8.2.6.1.5. Market size and forecast, by Age
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Key market trends, growth factors and opportunities
      • 8.2.6.2.2. Market size and forecast, by Product
      • 8.2.6.2.3. Market size and forecast, by Application
      • 8.2.6.2.4. Market size and forecast, by Design
      • 8.2.6.2.5. Market size and forecast, by Age
      • 8.2.6.3. Mexico
      • 8.2.6.3.1. Key market trends, growth factors and opportunities
      • 8.2.6.3.2. Market size and forecast, by Product
      • 8.2.6.3.3. Market size and forecast, by Application
      • 8.2.6.3.4. Market size and forecast, by Design
      • 8.2.6.3.5. Market size and forecast, by Age
  • 8.3. Europe
    • 8.3.1. Key trends and opportunities
    • 8.3.2. Market size and forecast, by Product
    • 8.3.3. Market size and forecast, by Application
    • 8.3.4. Market size and forecast, by Design
    • 8.3.5. Market size and forecast, by Age
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. Germany
      • 8.3.6.1.1. Key market trends, growth factors and opportunities
      • 8.3.6.1.2. Market size and forecast, by Product
      • 8.3.6.1.3. Market size and forecast, by Application
      • 8.3.6.1.4. Market size and forecast, by Design
      • 8.3.6.1.5. Market size and forecast, by Age
      • 8.3.6.2. France
      • 8.3.6.2.1. Key market trends, growth factors and opportunities
      • 8.3.6.2.2. Market size and forecast, by Product
      • 8.3.6.2.3. Market size and forecast, by Application
      • 8.3.6.2.4. Market size and forecast, by Design
      • 8.3.6.2.5. Market size and forecast, by Age
      • 8.3.6.3. UK
      • 8.3.6.3.1. Key market trends, growth factors and opportunities
      • 8.3.6.3.2. Market size and forecast, by Product
      • 8.3.6.3.3. Market size and forecast, by Application
      • 8.3.6.3.4. Market size and forecast, by Design
      • 8.3.6.3.5. Market size and forecast, by Age
      • 8.3.6.4. Italy
      • 8.3.6.4.1. Key market trends, growth factors and opportunities
      • 8.3.6.4.2. Market size and forecast, by Product
      • 8.3.6.4.3. Market size and forecast, by Application
      • 8.3.6.4.4. Market size and forecast, by Design
      • 8.3.6.4.5. Market size and forecast, by Age
      • 8.3.6.5. Spain
      • 8.3.6.5.1. Key market trends, growth factors and opportunities
      • 8.3.6.5.2. Market size and forecast, by Product
      • 8.3.6.5.3. Market size and forecast, by Application
      • 8.3.6.5.4. Market size and forecast, by Design
      • 8.3.6.5.5. Market size and forecast, by Age
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Key market trends, growth factors and opportunities
      • 8.3.6.6.2. Market size and forecast, by Product
      • 8.3.6.6.3. Market size and forecast, by Application
      • 8.3.6.6.4. Market size and forecast, by Design
      • 8.3.6.6.5. Market size and forecast, by Age
  • 8.4. Asia-Pacific
    • 8.4.1. Key trends and opportunities
    • 8.4.2. Market size and forecast, by Product
    • 8.4.3. Market size and forecast, by Application
    • 8.4.4. Market size and forecast, by Design
    • 8.4.5. Market size and forecast, by Age
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. Japan
      • 8.4.6.1.1. Key market trends, growth factors and opportunities
      • 8.4.6.1.2. Market size and forecast, by Product
      • 8.4.6.1.3. Market size and forecast, by Application
      • 8.4.6.1.4. Market size and forecast, by Design
      • 8.4.6.1.5. Market size and forecast, by Age
      • 8.4.6.2. China
      • 8.4.6.2.1. Key market trends, growth factors and opportunities
      • 8.4.6.2.2. Market size and forecast, by Product
      • 8.4.6.2.3. Market size and forecast, by Application
      • 8.4.6.2.4. Market size and forecast, by Design
      • 8.4.6.2.5. Market size and forecast, by Age
      • 8.4.6.3. Australia
      • 8.4.6.3.1. Key market trends, growth factors and opportunities
      • 8.4.6.3.2. Market size and forecast, by Product
      • 8.4.6.3.3. Market size and forecast, by Application
      • 8.4.6.3.4. Market size and forecast, by Design
      • 8.4.6.3.5. Market size and forecast, by Age
      • 8.4.6.4. India
      • 8.4.6.4.1. Key market trends, growth factors and opportunities
      • 8.4.6.4.2. Market size and forecast, by Product
      • 8.4.6.4.3. Market size and forecast, by Application
      • 8.4.6.4.4. Market size and forecast, by Design
      • 8.4.6.4.5. Market size and forecast, by Age
      • 8.4.6.5. South Korea
      • 8.4.6.5.1. Key market trends, growth factors and opportunities
      • 8.4.6.5.2. Market size and forecast, by Product
      • 8.4.6.5.3. Market size and forecast, by Application
      • 8.4.6.5.4. Market size and forecast, by Design
      • 8.4.6.5.5. Market size and forecast, by Age
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Key market trends, growth factors and opportunities
      • 8.4.6.6.2. Market size and forecast, by Product
      • 8.4.6.6.3. Market size and forecast, by Application
      • 8.4.6.6.4. Market size and forecast, by Design
      • 8.4.6.6.5. Market size and forecast, by Age
  • 8.5. LAMEA
    • 8.5.1. Key trends and opportunities
    • 8.5.2. Market size and forecast, by Product
    • 8.5.3. Market size and forecast, by Application
    • 8.5.4. Market size and forecast, by Design
    • 8.5.5. Market size and forecast, by Age
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Brazil
      • 8.5.6.1.1. Key market trends, growth factors and opportunities
      • 8.5.6.1.2. Market size and forecast, by Product
      • 8.5.6.1.3. Market size and forecast, by Application
      • 8.5.6.1.4. Market size and forecast, by Design
      • 8.5.6.1.5. Market size and forecast, by Age
      • 8.5.6.2. Saudi Arabia
      • 8.5.6.2.1. Key market trends, growth factors and opportunities
      • 8.5.6.2.2. Market size and forecast, by Product
      • 8.5.6.2.3. Market size and forecast, by Application
      • 8.5.6.2.4. Market size and forecast, by Design
      • 8.5.6.2.5. Market size and forecast, by Age
      • 8.5.6.3. South Africa
      • 8.5.6.3.1. Key market trends, growth factors and opportunities
      • 8.5.6.3.2. Market size and forecast, by Product
      • 8.5.6.3.3. Market size and forecast, by Application
      • 8.5.6.3.4. Market size and forecast, by Design
      • 8.5.6.3.5. Market size and forecast, by Age
      • 8.5.6.4. Rest of LAMEA
      • 8.5.6.4.1. Key market trends, growth factors and opportunities
      • 8.5.6.4.2. Market size and forecast, by Product
      • 8.5.6.4.3. Market size and forecast, by Application
      • 8.5.6.4.4. Market size and forecast, by Design
      • 8.5.6.4.5. Market size and forecast, by Age

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Top player positioning, 2021

CHAPTER 10: COMPANY PROFILES

  • 10.1. Evaheart, Inc.
    • 10.1.1. Company overview
    • 10.1.2. Key Executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
    • 10.1.6. Key strategic moves and developments
  • 10.2. Calon Cardio-Technology Ltd
    • 10.2.1. Company overview
    • 10.2.2. Key Executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
  • 10.3. Carmat SA
    • 10.3.1. Company overview
    • 10.3.2. Key Executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
    • 10.3.6. Key strategic moves and developments
  • 10.4. Fineheart
    • 10.4.1. Company overview
    • 10.4.2. Key Executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
    • 10.4.6. Key strategic moves and developments
  • 10.5. AdjuCor GmbH
    • 10.5.1. Company overview
    • 10.5.2. Key Executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
  • 10.6. Corewave SA
    • 10.6.1. Company overview
    • 10.6.2. Key Executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
    • 10.6.6. Key strategic moves and developments
  • 10.7. Bivacor Inc.
    • 10.7.1. Company overview
    • 10.7.2. Key Executives
    • 10.7.3. Company snapshot
    • 10.7.4. Operating business segments
    • 10.7.5. Product portfolio
    • 10.7.6. Key strategic moves and developments
  • 10.8. Windmill Cardiovascular Systems
    • 10.8.1. Company overview
    • 10.8.2. Key Executives
    • 10.8.3. Company snapshot
    • 10.8.4. Operating business segments
    • 10.8.5. Product portfolio
  • 10.9. NuPulseCV, Inc.
    • 10.9.1. Company overview
    • 10.9.2. Key Executives
    • 10.9.3. Company snapshot
    • 10.9.4. Operating business segments
    • 10.9.5. Product portfolio
  • 10.10. Abiomed, Inc.
    • 10.10.1. Company overview
    • 10.10.2. Key Executives
    • 10.10.3. Company snapshot
    • 10.10.4. Operating business segments
    • 10.10.5. Product portfolio
    • 10.10.6. Business performance
    • 10.10.7. Key strategic moves and developments
  • 10.11. LivaNova PLC
    • 10.11.1. Company overview
    • 10.11.2. Key Executives
    • 10.11.3. Company snapshot
    • 10.11.4. Operating business segments
    • 10.11.5. Product portfolio
    • 10.11.6. Business performance
    • 10.11.7. Key strategic moves and developments
  • 10.12. Berlin Heart GmbH
    • 10.12.1. Company overview
    • 10.12.2. Key Executives
    • 10.12.3. Company snapshot
    • 10.12.4. Operating business segments
    • 10.12.5. Product portfolio
    • 10.12.6. Key strategic moves and developments
  • 10.13. Jarvik Heart, Inc.
    • 10.13.1. Company overview
    • 10.13.2. Key Executives
    • 10.13.3. Company snapshot
    • 10.13.4. Operating business segments
    • 10.13.5. Product portfolio
  • 10.14. Abbott Laboratories
    • 10.14.1. Company overview
    • 10.14.2. Key Executives
    • 10.14.3. Company snapshot
    • 10.14.4. Operating business segments
    • 10.14.5. Product portfolio
    • 10.14.6. Business performance
    • 10.14.7. Key strategic moves and developments
  • 10.15. SynCardia Systems, LLC
    • 10.15.1. Company overview
    • 10.15.2. Key Executives
    • 10.15.3. Company snapshot
    • 10.15.4. Operating business segments
    • 10.15.5. Product portfolio
    • 10.15.6. Key strategic moves and developments
  • 10.16. CH Biomedical, Inc.
    • 10.16.1. Company overview
    • 10.16.2. Key Executives
    • 10.16.3. Company snapshot
    • 10.16.4. Operating business segments
    • 10.16.5. Product portfolio
    • 10.16.6. Key strategic moves and developments